Literature DB >> 26279873

Crystal structure of metronidazolium tetra-chlorido-aurate(III).

Patrick J Quinlivan1, Ja-Shin Wu2, Rita K Upmacis2.   

Abstract

Metronidazole n class="Chemical">(MET) [systematic names: 1-(2-hy-droxy-eth-yl)-2-methyl-5-nitro-1H-imidazole and 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol] is a medication that is used to treat infections from a variety of anaerobic organisms. As with other imidazole derivatives, metronidazole is also susceptible to protonation. However, there are few reports of the structures of metronidazolium derivatives. In the title compound, (C6H10N3O3)[AuCl4] [systematic name: 1-(2-hy-droxy-eth-yl)-2-methyl-5-nitro-1H-imidazol-3-ium tetra-chlorido-aur-ate(III)], the asymmetric unit consists of a metronidazolium cation, [H(MET)](+), and a tetra-chlorido-aurate(III) anion, [AuCl4](-), in which the Au(III) ion is in a slightly distorted square-planar coordination environment. In the cation, the nitro group is essentially coplanar with the imidazole ring, as indicated by an O N-C=C torsion angle of -0.2 (4)°, while the hy-droxy-ethyl group is in a coiled conformation, with an O(H)-C-C-N torsion angle of 62.3 (3)°. In the crystal, the anion and cation are linked by an inter-molecular O-H⋯Cl hydrogen bond. In addition, the N-H group of the metronidazolium ion serves as a hydrogen-bond donor to the O atom of the hy-droxy-ethyl group of a symmetry-related mol-ecule, leading to the formation of chains along [010].

Entities:  

Keywords:  O—H⋯Cl hydrogen bonding; crystal structure; flag­yl; gold; metronidazole; tetra­chlorido­aurate(III)

Year:  2015        PMID: 26279873      PMCID: PMC4518979          DOI: 10.1107/S2056989015010798

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

Metronidazole n class="Chemical">(MET), marketed as flagyl, and also known by the systematic names 1-(2-hy­droxy­eth­yl)-2-methyl-5-nitro-1H-imidazole and 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol, is a medication that has been used for the treatment of parasitic infections, such as trichomoniasis, amoebiasis and giardiasis, and is also effective against anaerobic bacteria (Freeman et al., 1997 ▸; Miljkovic et al., 2014 ▸; Soares et al., 2012 ▸; Samuelson, 1999 ▸; Lofmark et al., 2010 ▸; Contreras et al., 2009 ▸). Metronidazole possesses a variety of functional groups, and the two-coordinate nitro­gen atom of the imidazole ring has been shown to be an effective ligand for a variety of metals (Contreras et al., 2009 ▸). This nitro­gen atom is also susceptible to protonation, but there are few structures of metronidazolium derivatives reported in the literature (Yang, 2008 ▸; Wang et al., 2010 ▸). We describe herein the structure of metronidazolium tetra­chlorido­aurate(III), which is obtained by the addition of MET to HAuCl4.

Structural commentary

The asymmetric unit of [n class="Chemical">H(MET)][AuCl4] consists of a metronidazolium cation, [H(MET)]+, hydrogen-bonded to a square-planar tetra­chlorido­aurate(III) anion, [AuCl4]−, by an O—H⋯Cl hydrogen bond as illustrated in Fig. 1 ▸. The O3⋯Cl3 distance of 3.169 (2) Å is comparable to the values in other tetra­chlorido­aurate(III) derivatives that exhibit O—H⋯Cl hydrogen bonds. As an illustration, bis­{2-[(2-hy­droxy­eth­yl)imino­meth­yl]phenolato}gold(III) tetra­chlorido­aurate(III) possesses an O—H⋯Cl hydrogen bond between a hy­droxy­ethyl group and [AuCl4]−, with an O(H)⋯Cl distance of 3.365 Å (Nockemann et al., 2007 ▸). For further reference, the average O⋯Cl distance in compounds that have O—H⋯Cl inter­actions is 3.196 (3) Å (Steiner, 2002 ▸). The nitro group is almost coplanar with the imidazole ring, as indicated by an O1—N3—C2—C1 torsion angle of −0.2 (4)°, while the hy­droxy­ethyl group exhibits an O3—C6—C5—N2 torsion angle of 62.3 (3)°, describing a coiled conformation.
Figure 1

The asymmetric unit of the title compound, shown with 20% probability displacement ellipsoids. The O3—H3⋯Cl3 hydrogen bond is shown as an open bond.

Supra­molecular features

In the crystal, the N—H group of the metronidazolium ion serves as a n class="Chemical">hydrogen-bond donor to the oxygen atom of the hy­droxy­ethyl group of a symmetry-related mol­ecule, forming a chain along [010] in which each O—H group is O—H⋯Cl hydrogen bonded to a [AuCl4]− ion (Table 1 ▸ and Fig. 2 ▸). The N⋯O distance of 2.729 (3) Å associated with the hydrogen bond is comparable to that observed for metronidazole [2.816 (2) Å] (Blaton et al., 1979 ▸; Galván-Tejada et al., 2002 ▸). However, an important difference between the hydrogen bonds in metronidazole and metronidazolium is that the alcohol O—H group is the hydrogen-bond donor for metronidazole (i.e. O—H⋯N), while the N—H group is the hydrogen-bond donor for metronidazolium (i.e. N—H⋯O).
Table 1

Hydrogen-bond geometry (, )

DHA DHHA D A DHA
N1H01O3i 0.94(4)1.81(4)2.729(3)166(3)
O3H3Cl30.67(4)2.54(4)3.169(2)158(4)

Symmetry code: (i) .

Figure 2

Part of the crystal structure showing a hydrogen-bonded chain (open bonds) along [010].

Database survey

Metronidazolium derivatives that feature other counter-ions, e.g. 3-carb­oxy-4-hy­droxy­benzene­sulfonate and n class="Chemical">perchlorate have been reported (Yang, 2008 ▸; Wang et al., 2010 ▸), as have a variety of tetra­chlorido­aurate(III) complexes (Johnson & Steed, 1998 ▸; Pluzhnik-Gladyr et al., 2014 ▸; Faza­eli et al., 2010 ▸).

Synthesis and crystallization

Crystals of composition [H(MET)][n class="Chemical">AuCl4] were obtained by combining HAuCl4·H2O (0.12 mmol) with MET (0.20 mmol) in MeOH (2 ml), followed by evaporation of MeOH, and crystallization from Et2O.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. H atoms bonded to C atoms were refined with a riding model, with C—H = 0.95–0.99 Å and U iso(H) = 1.2U eq(C) or 1.5U eq(Cn class="Chemical">meth­yl). H atoms bonded to N and O atoms were refined independently with isotropic displacement parameters.
Table 2

Experimental details

Crystal data
Chemical formula(C6H10N3O3)[AuCl4]
M r 510.94
Crystal system, space groupMonoclinic, P21/n
Temperature (K)130
a, b, c ()7.324(2), 11.972(4), 15.667(5)
()94.384(4)
V (3)1369.6(8)
Z 4
Radiation typeMo K
(mm1)11.52
Crystal size (mm)0.23 0.04 0.02
 
Data collection
DiffractometerBruker APEXII CCD
Absorption correctionMulti-scan (SADABS; Bruker, 2013)
T min, T max 0.426, 0.746
No. of measured, independent and observed [I > 2(I)] reflections22024, 4214, 3673
R int 0.041
(sin /)max (1)0.718
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.021, 0.045, 1.16
No. of reflections4214
No. of parameters163
H-atom treatmentH atoms treated by a mixture of independent and constrained refinement
max, min (e 3)1.30, 1.22

Computer programs: APEX2 and, SAINT (Bruker, 2013 ▸), SHELXS97 and SHELXTL (Sheldrick, 2008 ▸), SHELXL2014 (Sheldrick, 2015 ▸).

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015010798/lh5766sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015010798/lh5766Isup3.hkl CCDC reference: 1404845 Additional supporting information: crystallographic information; 3D view; checkCIF report
(C6H10N3O3)[AuCl4]F(000) = 952
Mr = 510.94Dx = 2.478 Mg m3
Monoclinic, P21/nMo Kα radiation, λ = 0.71073 Å
a = 7.324 (2) ÅCell parameters from 9874 reflections
b = 11.972 (4) Åθ = 2.6–30.6°
c = 15.667 (5) ŵ = 11.52 mm1
β = 94.384 (4)°T = 130 K
V = 1369.6 (8) Å3Plate, yellow
Z = 40.23 × 0.04 × 0.02 mm
Bruker APEXII CCD diffractometer3673 reflections with I > 2σ(I)
φ and ω scansRint = 0.041
Absorption correction: multi-scan (SADABS; Bruker, 2013)θmax = 30.7°, θmin = 2.1°
Tmin = 0.426, Tmax = 0.746h = −10→10
22024 measured reflectionsk = −17→17
4214 independent reflectionsl = −22→22
Refinement on F20 restraints
Least-squares matrix: fullHydrogen site location: mixed
R[F2 > 2σ(F2)] = 0.021H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.045w = 1/[σ2(Fo2) + (0.0129P)2] where P = (Fo2 + 2Fc2)/3
S = 1.16(Δ/σ)max = 0.001
4214 reflectionsΔρmax = 1.30 e Å3
163 parametersΔρmin = −1.22 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
xyzUiso*/Ueq
Au0.36629 (2)0.79983 (2)0.58625 (2)0.01868 (4)
Cl10.26070 (11)0.84595 (7)0.45047 (5)0.03247 (17)
Cl20.44092 (10)0.62541 (6)0.54111 (5)0.03012 (16)
Cl30.46029 (10)0.75210 (6)0.72389 (5)0.02610 (15)
Cl40.29498 (10)0.97418 (6)0.63205 (5)0.02831 (15)
O10.8047 (3)0.7553 (2)0.41611 (14)0.0367 (5)
O20.9242 (3)0.60835 (18)0.47815 (14)0.0331 (5)
O30.7450 (3)0.55236 (18)0.73360 (15)0.0265 (5)
H30.684 (5)0.591 (3)0.719 (2)0.042 (13)*
N10.8446 (3)0.89061 (19)0.65413 (15)0.0175 (4)
H010.810 (5)0.953 (3)0.685 (2)0.042 (10)*
N20.9387 (3)0.72022 (17)0.63739 (14)0.0159 (4)
N30.8670 (3)0.70319 (19)0.47846 (15)0.0223 (5)
C10.8127 (4)0.8685 (2)0.56913 (17)0.0191 (5)
H1A0.76040.91730.52610.023*
C20.8708 (3)0.7626 (2)0.55853 (17)0.0158 (5)
C30.9200 (4)0.8016 (2)0.69521 (17)0.0170 (5)
C40.9783 (4)0.7982 (3)0.78720 (19)0.0272 (6)
H4A0.93180.86430.81540.041*
H4B1.11230.79720.79490.041*
H4C0.92950.73070.81260.041*
C51.0107 (4)0.6070 (2)0.65912 (18)0.0198 (5)
H5A1.08630.61020.71420.024*
H5B1.09040.58220.61450.024*
C60.8579 (4)0.5230 (2)0.66604 (18)0.0227 (6)
H6A0.78180.51990.61110.027*
H6B0.91110.44790.67730.027*
U11U22U33U12U13U23
Au0.01490 (5)0.01746 (6)0.02409 (6)−0.00147 (4)0.00416 (4)−0.00253 (4)
Cl10.0438 (4)0.0304 (4)0.0234 (4)0.0042 (3)0.0037 (3)−0.0009 (3)
Cl20.0286 (4)0.0222 (3)0.0400 (4)0.0024 (3)0.0057 (3)−0.0092 (3)
Cl30.0255 (3)0.0251 (3)0.0272 (4)0.0036 (3)−0.0008 (3)−0.0012 (3)
Cl40.0360 (4)0.0193 (3)0.0292 (4)0.0033 (3)0.0002 (3)−0.0038 (3)
O10.0516 (15)0.0375 (13)0.0193 (11)0.0047 (11)−0.0090 (10)−0.0008 (10)
O20.0468 (14)0.0221 (11)0.0309 (12)0.0056 (10)0.0058 (10)−0.0077 (9)
O30.0250 (11)0.0233 (11)0.0327 (13)0.0053 (9)0.0109 (9)0.0075 (9)
N10.0172 (10)0.0152 (10)0.0203 (11)−0.0003 (9)0.0023 (9)−0.0003 (9)
N20.0146 (10)0.0157 (10)0.0175 (11)0.0000 (8)0.0021 (8)0.0014 (8)
N30.0253 (12)0.0233 (12)0.0181 (12)−0.0032 (10)0.0010 (9)−0.0019 (9)
C10.0217 (13)0.0198 (13)0.0157 (12)0.0003 (10)−0.0001 (10)0.0012 (10)
C20.0184 (12)0.0152 (11)0.0138 (12)−0.0023 (10)0.0008 (9)−0.0006 (9)
C30.0146 (12)0.0188 (12)0.0180 (13)−0.0012 (10)0.0038 (10)0.0002 (10)
C40.0292 (16)0.0355 (17)0.0167 (14)0.0031 (13)0.0011 (12)−0.0009 (12)
C50.0181 (12)0.0170 (12)0.0245 (14)0.0051 (10)0.0026 (10)0.0064 (10)
C60.0254 (14)0.0164 (13)0.0271 (15)0.0029 (11)0.0072 (12)0.0046 (11)
Au—Cl12.2752 (10)N2—C51.485 (3)
Au—Cl42.2807 (9)N3—C21.441 (3)
Au—Cl22.2844 (9)C1—C21.351 (4)
Au—Cl32.2855 (10)C1—H1A0.9500
O1—N31.218 (3)C3—C41.472 (4)
O2—N31.210 (3)C4—H4A0.9800
O3—C61.436 (3)C4—H4B0.9800
O3—H30.67 (4)C4—H4C0.9800
N1—C31.341 (3)C5—C61.515 (4)
N1—C11.360 (3)C5—H5A0.9900
N1—H010.94 (4)C5—H5B0.9900
N2—C31.345 (3)C6—H6A0.9900
N2—C21.392 (3)C6—H6B0.9900
Cl1—Au—Cl490.14 (3)N1—C3—N2108.2 (2)
Cl1—Au—Cl290.27 (3)N1—C3—C4124.7 (2)
Cl4—Au—Cl2179.36 (3)N2—C3—C4127.0 (2)
Cl1—Au—Cl3177.66 (3)C3—C4—H4A109.5
Cl4—Au—Cl389.52 (3)C3—C4—H4B109.5
Cl2—Au—Cl390.09 (3)H4A—C4—H4B109.5
C6—O3—H3108 (3)C3—C4—H4C109.5
C3—N1—C1110.4 (2)H4A—C4—H4C109.5
C3—N1—H01120 (2)H4B—C4—H4C109.5
C1—N1—H01129 (2)N2—C5—C6111.8 (2)
C3—N2—C2106.6 (2)N2—C5—H5A109.3
C3—N2—C5124.1 (2)C6—C5—H5A109.3
C2—N2—C5129.3 (2)N2—C5—H5B109.3
O2—N3—O1125.9 (3)C6—C5—H5B109.3
O2—N3—C2118.9 (2)H5A—C5—H5B107.9
O1—N3—C2115.2 (2)O3—C6—C5111.1 (2)
C2—C1—N1105.7 (2)O3—C6—H6A109.4
C2—C1—H1A127.1C5—C6—H6A109.4
N1—C1—H1A127.1O3—C6—H6B109.4
C1—C2—N2109.1 (2)C5—C6—H6B109.4
C1—C2—N3125.8 (2)H6A—C6—H6B108.0
N2—C2—N3125.1 (2)
D—H···AD—HH···AD···AD—H···A
N1—H01···O3i0.94 (4)1.81 (4)2.729 (3)166 (3)
O3—H3···Cl30.67 (4)2.54 (4)3.169 (2)158 (4)
  13 in total

Review 1.  Why metronidazole is active against both bacteria and parasites.

Authors:  J Samuelson
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

2.  The hydrogen bond in the solid state.

Authors:  Thomas Steiner
Journal:  Angew Chem Int Ed Engl       Date:  2002-01-04       Impact factor: 15.336

Review 3.  Interactions of metronidazole with other medicines: a brief review.

Authors:  V Miljkovic; B Arsic; Z Bojanic; G Nikolic; Lj Nikolic; B Kalicanin; V Savic
Journal:  Pharmazie       Date:  2014-08       Impact factor: 1.267

4.  Halogen impact into new oxonium benzo-crown ether complexes with tetrachloro- and tetrabromoaurates(III).

Authors:  Sergei M Pluzhnik-Gladyr; Victor Ch Kravtsov; Marina S Fonari; Gerbert L Kamalov
Journal:  Dalton Trans       Date:  2014-03-26       Impact factor: 4.390

5.  Supramolecular structures of metronidazole and its copper(II), cobalt(II) and zinc(II) coordination compounds.

Authors:  Nadeshda Galván-Tejada; Sylvain Bernès; Silvia E Castillo-Blum; Heinrich Nöth; Ramon Vicente; Noráh Barba-Behrens
Journal:  J Inorg Biochem       Date:  2002-07-25       Impact factor: 4.155

6.  Bis(tribenzyl-ammonium) tetra-chloridoaurate(III) chloride.

Authors:  Yousef Fazaeli; Vahid Amani; Mostafa M Amini; Hamid Reza Khavasi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-01-30

7.  1-Hydroxy-ethyl-2-methyl-5-nitro-imidazolium 3-carb-oxy-4-hydroxy-benzene-sulfonate.

Authors:  Bo Yang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-06-25

Review 8.  Metronidazole is still the drug of choice for treatment of anaerobic infections.

Authors:  Sonja Löfmark; Charlotta Edlund; Carl Erik Nord
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

9.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

Review 10.  Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs.

Authors:  Geisla Mary Silva Soares; Luciene Cristina Figueiredo; Marcelo Faveri; Sheila Cavalca Cortelli; Poliana Mendes Duarte; Magda Feres
Journal:  J Appl Oral Sci       Date:  2012 May-Jun       Impact factor: 2.698

View more
  1 in total

1.  Evaluation of the effect of 1,3-bis-(4-phenyl-[1,2,3] triazole-1-il)2-propanol in comparison with metronidazole in an in vitro culture of Blastocystis in samples of patients with irritable bowel syndrome.

Authors:  L García-Flores; J G Santillán-Benítez; E Cuevas-Yáñez; P Caballero-Vásquez; S Zamudio-Chávez; E Morales-Ávila
Journal:  J Parasit Dis       Date:  2019-05-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.